Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
1,991
+50
+3% +$9.06K 0.1% 140
2026
Q1
$286K Sell
1,941
-1,146
-37% -$186K 0.11% 131
2025
Q4
$602K Buy
3,087
+265
+9% +$63.1K 0.25% 76
2025
Q3
$794K Buy
2,822
+498
+21% +$127K 0.35% 52
2025
Q2
$508K Buy
2,324
+153
+7% +$24.7K 0.27% 64
2025
Q1
$303K Buy
2,171
+124
+6% +$20.2K 0.17% 102
2024
Q4
$341K Sell
2,047
-17
-0.8% -$3.02K 0.19% 87
2024
Q3
$352K Buy
2,064
+132
+7% +$19.1K 0.18% 80
2024
Q2
$273K Buy
1,932
+25
+1% +$3.1K 0.13% 92
2024
Q1
$240K Buy
+1,907
New +$218K 0.11% 104

Other funds holding ORCL

Traveka Wealth's ORCL Position: Q2 2026 in Review

Traveka Wealth increased its Oracle (ORCL) stake by 2.6% in Q2 2026, buying an estimated $9.06K and bringing the position to 1,991 shares worth $292K. The position accounts for 0.1% of the portfolio, ranked #140.

Traveka Wealth first reported a position in ORCL in Q1 2024 and has held it in 10 quarters since. The position peaked at $794K in Q3 2025. 1,778 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Traveka Wealth held 1,991 shares of Oracle worth $292K as of Q2 2026.
  • Traveka Wealth bought 50 Oracle shares in Q2 2026, an estimated $9.06K.
  • Oracle made up 0.1% of Traveka Wealth's portfolio in Q2 2026, its #140 holding.
  • Traveka Wealth first reported a position in Oracle in Q1 2024 and has held it in 10 quarters since.
  • Traveka Wealth's Oracle position peaked at $794K in Q3 2025.
  • 1,778 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.